Aequus Pharmaceuticals Inc V.AQS

Alternate Symbol(s): AQSZF

Healthcare

Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on developing and commercializing, differentiated products in ophthalmology. Its pipeline products include PAUL Glaucoma Implant, ZIMED PF, and REV-0100 / ReVision. PAUL is a glaucoma drainage device designed to regulate intraocular pressure in the patient’s eyes and prevent further progression of the disease. PAUL has introduced many design features and unified these into one device and offers a solution for patients with moderate to severe glaucoma. ZIMED PF is the first available multi-dose, preservative free, bimatoprost containing product in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. REV-0100 works by reducing levels of a toxic lipid called lipid bisretinoid, which accumulates within the retina in material called lipofuscin.

TSXV:AQS - Post by User

Aequus Pharmaceuticals Inc

Bullboard Posts

Comment by Njdevilsfanon May 02, 2017 2:54pm

119 Views

Post# 26193923

RE: DIRT CHEAP MC of $15M/ profitability by year end =20 BAGGER

and it's getting cheaper. down another 8% right now on heavy volume. investors didn't care for #'s or presentation and bloom burton. revenues did not exceed $200,000 last quarter but your video that you keep posting over and over and over again suggest $45 million plus at some point. that is some ramp up. hope it works out for them as i own shares but i think you're a snake

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale